/DatalocitiScreenbi.jpg)
|
 |
Cancer Mart Solution
Superior solutions and value that help you manage your business.
The Cancer Mart attempts to answer cancer questions that enable decision makers to respond strategically. Additionally, the Cardiology Mart improve patient care and optimize resource management by tracking and predicting.
Increase workflow efficiencies by analyzing consolidated data from clinical, administrative, and financial areas
- Improve patient care and optimize resource management by tracking and predicting healthcare service utilization
- Meet government legislative controls by delivering measured and accountable patient-centric care metrics
- Monitor and analyze patient diagnosis and condition to facilitate timely and effective clinical decisions
- Control costs, improve contracting decisions, and eliminate waste by closely managing inventory and provider performances
- Increase efficiency and detect fraud by analyzing historical information, and tracking and closely monitoring current claims data
The following table gives the estimated numbers of new cases and deaths for each common cancer type:
| Cancer Type |
Estimated New Cases |
Estimated Deaths |
Bladder |
67,160 |
13,750 |
Breast (Female -- Male) |
178,480 -- 2,030 |
40,460 -- 450 |
Colon and Rectal (Combined) |
153,760 |
52,180 |
Endometrial |
39,080 |
7,400 |
Kidney (Renal Cell) Cancer |
43,512 |
10,957 |
Leukemia (All) |
44,240 |
21,790 |
Lung (Including Bronchus) |
213,380 |
160,390 |
Melanoma |
59,940 |
8,110 |
Non-Hodgkin's Lymphoma |
63,190 |
18,660 |
Pancreatic |
37,170 |
33,370 |
Prostate |
218,890 |
27,050 |
Skin (Non-melanoma) |
>1,000,000 |
<2,000 |
Thyroid |
33,550 |
1,530 |
References
- American Cancer Society: Cancer Facts and Figures 2007. Atlanta, Ga: American Cancer Society, 2007. Also available online. Last accessed January 18, 2007.
- Lipworth L, Tarone RE, McLaughlin JK: The epidemiology of renal cell carcinoma. Journal of Urology 176(6 pt 1):2353-2358, 2006. [PUBMED Abstract]
|
|
History & Acknoledgement
What is the Cancer Trends Progress Report – 2005 Update?
The National Cancer Institute's Cancer Trends Progress Report – 2005 Update is an online report that tracks the nation's progress against cancer across the full cancer continuum – from prevention through the impact of deaths from cancer. |
Why is the report important?
It is the only report of its kind to present—all in one place—the most up-to-date information on trends in the nation's progress against cancer, gathered through a collaborative effort with other key cancer agencies and groups, including the National Cancer Institute, the Centers for Disease Control and Prevention, other federal agencies, professional groups, and cancer researchers. |
What is the main message of the report?
The nation has met or is making progress toward a number of major cancer-related Healthy People 2010 targets. However, we are losing ground in other important areas that demand attention. |
What is in the report?
The report includes key measures in the areas of prevention, screening, diagnosis, life after cancer, and the end of life. Progress is tracked over time, with the initial year depending on the available data. This progress is measured against certain cancer-related targets of Healthy People 2010. |
EPA Report
National cancer death rates declined overall during the 1990s,7 but cancer is still the second-leading cause of death in the U.S., and the number of people who develop cancer each year has actually increased since 1973.8 Although the overall death rates have dropped for some types—leukemia and breast, cervical, colorectal, stomach, and uterine cancers—the death rates for lung cancer and skin cancer, the most common type of cancer in the country, have increased.9 The number of people developing cancer shows the same mixed results for different subsets of the U.S. population. For example, lung cancer rates have declined for men but increased for women since 1973, and leukemia rates have declined among adults but not among children.10
|
|
|
|